The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
Open accessAbstract
Mechanistic target of rapamycin (mTOR, also known as mammalian target of rapamycin) is a ubiquitous serine/threonine kinase that regulates cell growth, proliferation and survival. These effects are cell-type-specific, and are elicited in response to stimulation by growth factors, hormones and cytokines, as well as to internal and external metabolic cues. Rapamycin was initially developed as an inhibitor of T-cell proliferation and allograft rejection in the organ transplant setting. Subsequently, its molecular target (mTOR) was identified as a component of two interacting complexes, mTORC1 and mTORC2, that regulate T-cell lineage specification and macrophage differentiation. mTORC1 drives the proinflammatory expansion of T helper (TH) type 1, TH17, and CD4−CD8− (double-negative, DN) T cells. Both mTORC1 and mTORC2 inhibit the development of CD4+CD25+FoxP3+ T regulatory (TREG) cells and, indirectly, mTORC2 favours the expansion of T follicular helper (TFH) cells which, similarly to DN T cells, promote B-cell activation and autoantibody production. In contrast to this proinflammatory effect of mTORC2, mTORC1 favours, to some extent, an anti-inflammatory macrophage polarization that is protective against infections and tissue inflammation. Outside the immune system, mTORC1 controls fibroblast proliferation and chondrocyte survival, with implications for tissue fibrosis and osteoarthritis, respectively. Rapamycin (which primarily inhibits mTORC1), ATP-competitive, dual mTORC1/mTORC2 inhibitors and upstream regulators of the mTOR pathway are being developed to treat autoimmune, hyperproliferative and degenerative diseases. In this regard, mTOR blockade promises to increase life expectancy through treatment and prevention of rheumatic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–231 of 231
Matched and mismatched metabolic fuels in lymphocyte function
Caro‐Maldonado, A., Gerriets, V. A., & Rathmell, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.002 · Cited by 47
Chamberlain, M. D., Chan, T., Oberg, J. C., Hawrysh, A. D., James, K. M., Saxena, A., Xiang, J., & Anderson, D. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800941200 · Cited by 45
Rapamycin: In Vitro Profile of a New Immunosuppressive Macrolide.
Sehgal, S. N., & Bansbach, C. C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb35852.x · Cited by 44
Rapamycin in experimental renal allografts in dogs and pigs.
Collier, D. S., Calne, R. Y., Thiru, S. S., Lim, S. H., Pollard, S. G., Barron, P., Costa, M. D., & White, D. J. (1990) · PubMed · Cited by 44
GATA-3 Regulates the Homeostasis and Activation of CD8+ T Cells
Tai, T.-S., Pai, S., & Ho, I. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201361 · Cited by 43
Mechanical activation of mammalian target of rapamycin pathway is required for cartilage development
Guan, Y. A., Yang, X., Yang, W., Charbonneau, C., & Chen, Q. (2014) · The FASEB Journal · doi:10.1096/fj.14-252783 · Cited by 41
Qi, W., Huang, Y., Yao, Y., Shen, Z., & Min, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065166 · Cited by 40
Akt-Dependent Enhanced Migratory Capacity of Th17 Cells from Children with Lupus Nephritis
Kshirsagar, S., Riedl, M., Billing, H., Tönshoff, B., Thangavadivel, S., Steuber, C., Staude, H., Wechselberger, G., & Edelbauer, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400044 · Cited by 39
Deregulation of Rab5 and Rab4 proteins in p85R274A-expressing cells alters PDGFR trafficking
Chamberlain, M. D., Oberg, J. C., Furber, L. A., Poland, S. F., Hawrysh, A. D., Knafelc, S. M., McBride, H. M., & Anderson, D. H. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.025 · Cited by 38
Li, K., Wu, C.-H., Hsieh, S., Lu, M., Tsai, C., & Yu, C. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/548516 · Cited by 38
A Double-blind, Cross-over, Study of Oral N-Acetylcysteine in Sjögren’s Syndrome
Walters, M. T., Rubin, C. E., Keightley, S. J., et al. (1986) · Scandinavian Journal of Rheumatology · doi:10.1080/15027732.1986.12461423 · Cited by 38
Otaki, N., Chikazawa, M., Nagae, R., Shimozu, Y., Shibata, T., Ito, S., Takasaki, Y., Fujii, J., & Uchida, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165175 · Cited by 37
Kooijman, R., Lauf, J., Kappers, A. C., & Rijkers, G. T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.2.593 · Cited by 37
Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis
Peled, M., Strazza, M., Azoulay‐Alfaguter, I., & Mor, A. (2015) · Inflammation · doi:10.1007/s10753-015-0132-2 · Cited by 36
Tuberous Sclerosis and Fulminant Lupus in a Young Woman
Singh, N., Birkenbach, M. P., Caza, T. N., Perl, A., & Cohen, P. L. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318289c033 · Cited by 35
Self-citationEfficacy of rapamycin in patient with juvenile rheumatoid arthritis
Foroncewicz, B., Mucha, K., Pączek, L., Chmura, A., & Rowinski, W. A. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00070.x · Cited by 34
Oxidative stress and Treg depletion in lupus patients with anti-phospholipid syndrome
Lai, Z., Marchena, I., & Perl, A. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.024 · Cited by 32
Self-citationCruzado, J. M., Poveda, R., Ibernón, M., Encarnación, M. M. D., Fulladosa, X., Carrera, M., Torras, J., Bestard, O., Navarro, I., Ballarín, J., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr072 · Cited by 31
Xu, W., Yang, X., Li, D.-H., Zheng, K., Qiu, P., Zhang, W., Li, C., Lei, K.-F., Yan, G., Jin, S., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.09.014 · Cited by 25
Balasubramaniam, S., Wamelink, M. M. C., Ngu, L. H., Talib, A., Salomons, G. S., Jakobs, C., & Teik, K. W. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181f50388 · Cited by 25
Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms
Tian, J., Wang, Y., Liu, X., Zhou, X., & Li, R. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214555666 · Cited by 21
Nambiar, M. P., Fisher, C. U., Enyedy, E. J., Warke, V. G., Kumar, A., & Tsokos, G. C. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00006-0 · Cited by 20
Tomasoni, R., Basso, V., Pilipow, K., Sitia, G., Saccani, S., Agresti, A., Mietton, F., Natoli, G., Colombetti, S., & Mondino, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201041130 · Cited by 19
Constantinescu, A., Liang, M., & Laskow, D. A. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34544 · Cited by 18
PTENtiating autoimmunity through Treg cell deregulation
Ray, J. P., & Craft, J. E. (2015) · Nature Immunology · doi:10.1038/ni.3082 · Cited by 14
Peng, L., Zhou, Y., Ye, X., & Zhao, Q. (2014) · Tumor Biology · doi:10.1007/s13277-014-2669-3 · Cited by 14
Kausch, C., Hamann, A., Uphues, I., Niendorf, A., Müller‐Wieland, D., Joost, H., Algenstaedt, P., Dreyer, M., Rüdiger, H. W., Häring, H., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6347 · Cited by 9
Limited Utility of Rapamycin in Severe, Refractory Wegener’s Granulomatosis
Koening, C. L., Hernández‐Rodríguez, J., Molloy, E. S., Clark, T. M., & Hoffman, G. S. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080664 · Cited by 8
A 50‐Year‐Old Woman With Cowden Syndrome and Joint Pains
Sagar, V., Bond, J. R., & CHOWDHARY, V. R. (2015) · Arthritis Care & Research · doi:10.1002/acr.22616 · Cited by 7
Systemic lupus erythematosus in a patient withPTENhamartoma tumour syndrome
Lee, T. Y. H., Le, E. N., Glass, D. A., Bowen, C. D., & Dominguez, A. R. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12767 · Cited by 5
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Self-citation
Cited by
Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Moulton, V. R., Suarez-Fueyo, A., Meidan, E., Li, H., Mizui, M., & Tsokos, G. C. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.05.006 · Cited by 469
Solleiro-Villavicencio, H., & Rivas-Arancibia, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00114 · Cited by 463
Lai, Z.-W., Kelly, R., Winans, T., Marchena, I., Shadakshari, A., Yu, J., Dawood, M., Garcia, R., Tily, H., Francis, L., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30485-9 · Cited by 412
Self-citationFibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis
Bustamante, M. F., Garcia-Carbonell, R., Whisenant, K. D., & Guma, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1303-3 · Cited by 407
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
Metadata
- Authors
- Perl, A.
- Venue
- Nature Reviews Rheumatology
- Published
- 2015-12-24
- Volume
- 12
- Issue
- 3
- Pages
- 169-182
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2238610105
- Cited by
- 332
- References
- 231
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.